CONTENT AND LEARNING OBJECTIVES

Recent research suggests a correlation between Inflammatory Bowel Disease (IBD) and Coeliac Disease (CD), revealing a noteworthy connection between these two conditions. Effective management and treatment strategies should address both conditions simultaneously beyond conventional dietary plans. Could probiotics play a role in symptom management? This webinar will explore the microbiome of IBD and CD, analysing current principles and concepts on how probiotics might influence both conditions, with a focus on their mechanisms related to the pathogenesis of each disease.

During this webinar, specialized researchers and expert dietitians, Dr. Bridgette Wilson and Cristian Costas Batlle, will present the latest research findings on the association between IBD and CD, along with the potential role of probiotics in prophylactic and dietary management. The literature concerning gut microbiome composition in these conditions will be reviewed, exploring whether probiotics could serve as a viable treatment option through their ability to alter microbiome composition and other mechanisms.

We’ll cover:

• The association between IBD and CD
• The mechanisms of action and current evidence base for the role of probiotics in both IBD and CD
• How to identify what patients/clients may benefit from probiotics
• Future research needed to extend understanding of this area

CPD CERTIFICATE & LEARNING MATERIALS

This webinar has been approved for CPD by the AfN

Webinar slides and links to other key resources will be sent within 2 weeks of viewing the webinar, along with a separate personalised CPD certificate to save for your files. Add hello@mynutriweb.com to your safe senders to ensure you receive them.

This webinar is being run in association with Optibac Probiotics and BDA Gastroenterology Specialist Group

About Optibac Probiotics

Optibac are experts and leaders in the market of probiotics in UK and Ireland. With 2 decades of expertise specialising entirely in probiotics formulations, they understand the importance of strain specificity, a fact recognised by WHO and IPA. This acknowledgement drives Optibac to partner with leading microbial institutes worldwide and work with some of the most extensively researched strains available, reflecting the company’s commitment to quality. Every Optibac strain undergoes rigorous testing to ensure they reach the gut alive. Education is another cornerstone of their values.

Learn more about Optibac research and gain access to their professional probiotics database (home to the most up to date research on individual strains).

About BDA Gastroenterology Specialist Group

The Gastroenterology Group of the British Dietetic Association is a specialist group which is open for all BDA members with a keen interest in all things gastrointestinal. We support and develop high quality evidence based dietetic practice in Gastroenterology and Hepatology, through the channels of social media, event days and resources. All whilst, promoting the benefit of a dietitian’s role in this unique specialism.